FDA Import Refusal SCS-8668088-5/11/1 — Cipla Pvt Ltd
The FDA refused shipment SCS-8668088-5/11/1 from Cipla Pvt Ltd (India) on Apr 15, 2025. The refused product falls under Drugs and Biologics — LISINOPRIL (ANTI-HYPERTENSIVE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Apr 15, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62CDA65 LISINOPRIL (ANTI-HYPERTENSIVE)
- Charges
- 75